By JAN YUMUL in Hong Kong | China Daily | Updated: 2021-03-11 10:29 Share CLOSE A booth displaying a coronavirus vaccine candidate from China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, in this September 4, 2020 file photo. [Photo/Agencies]
Shipments of vital jabs across region fuel optimism for return to normalcy
China s COVID-19 vaccines have come a long way in the Middle East. They were the first of the global offerings to secure authorization for emergency use there and one of them led a poll as the vaccine of choice in the region. To top that off, they have scored high on efficacy ratings.